FDA Issues Two Guidances to Boost First-In-Human Studies

Devices & Diagnostics Letter
The FDA proposes to streamline device clinical trials in a pair of draft guidances outlining requirements for early feasibility studies and explaining when a trial can begin even when there are outstanding issues with an Investigational Device Exemption (IDE) submission.

To View This Article:


Subscribe To Devices & Diagnostics Letter